These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

460 related items for PubMed ID: 10606314

  • 1. Immunnohistological assessment of intestinal eosinophil activation in patients with eosinophilic gastroenteritis and inflammatory bowel disease.
    Bischoff SC, Mayer J, Nguyen QT, Stolte M, Manns MP.
    Am J Gastroenterol; 1999 Dec; 94(12):3521-9. PubMed ID: 10606314
    [Abstract] [Full Text] [Related]

  • 2. Fecal eosinophil granule-derived proteins reflect disease activity in inflammatory bowel disease.
    Saitoh O, Kojima K, Sugi K, Matsuse R, Uchida K, Tabata K, Nakagawa K, Kayazawa M, Hirata I, Katsu K.
    Am J Gastroenterol; 1999 Dec; 94(12):3513-20. PubMed ID: 10606313
    [Abstract] [Full Text] [Related]

  • 3. Increased fecal eosinophil cationic protein in inflammatory bowel disease.
    Berstad A, Børkje B, Riedel B, Elsayed S, Berstad A.
    Hepatogastroenterology; 1993 Jun; 40(3):276-8. PubMed ID: 8325594
    [Abstract] [Full Text] [Related]

  • 4. Mucosal synthesis and release of prostaglandin E2 from activated eosinophils and macrophages in ulcerative colitis.
    Raab Y, Sundberg C, Hällgren R, Knutson L, Gerdin B.
    Am J Gastroenterol; 1995 Apr; 90(4):614-20. PubMed ID: 7717321
    [Abstract] [Full Text] [Related]

  • 5. Increased intraluminal release of eosinophil granule proteins EPO, ECP, EPX, and cytokines in ulcerative colitis and proctitis in segmental perfusion.
    Carlson M, Raab Y, Peterson C, Hällgren R, Venge P.
    Am J Gastroenterol; 1999 Jul; 94(7):1876-83. PubMed ID: 10406252
    [Abstract] [Full Text] [Related]

  • 6. Patients with psoriasis have elevated levels of serum eosinophil cationic protein and increased numbers of EG2 positive eosinophils in the duodenal stroma.
    Michaëlsson G, Kraaz W, Gerdén B, Hagforsen E, Lundin IP, Lööf L, Sj-oberg O, Scheynius A.
    Br J Dermatol; 1996 Sep; 135(3):371-8. PubMed ID: 8949428
    [Abstract] [Full Text] [Related]

  • 7. Study of release of eosinophil cationic proteins (ECP and EPX) in the hypereosinophilic syndrome (HES) and other hypereosinophilic conditions.
    Bobbio-Pallavicini E, Confalonieri M, Tacconi F, Mainardi E, Della Porta R, Ceccato D, Maccario R, De Amici M.
    Panminerva Med; 1998 Sep; 40(3):186-90. PubMed ID: 9785914
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Immunohistochemical study of intestinal eosinophils in inflammatory bowel disease.
    Carvalho AT, Elia CC, de Souza HS, Elias PR, Pontes EL, Lukashok HP, de Freitas FC, Lapa e Silva JR.
    J Clin Gastroenterol; 2003 Feb; 36(2):120-5. PubMed ID: 12544193
    [Abstract] [Full Text] [Related]

  • 10. Activation of eosinophils in the pathophysiology of ulcerative colitis.
    Makiyama K, Kanzaki S, Yamasaki K, Zea-Iriarte W, Tsuji Y.
    J Gastroenterol; 1995 Nov; 30 Suppl 8():64-9. PubMed ID: 8563894
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. CD40 and CD86 upregulation with divergent CMRF44 expression on blood dendritic cells in inflammatory bowel diseases.
    Vuckovic S, Florin TH, Khalil D, Zhang MF, Patel K, Hamilton I, Hart DN.
    Am J Gastroenterol; 2001 Oct; 96(10):2946-56. PubMed ID: 11693331
    [Abstract] [Full Text] [Related]

  • 13. [The changes of EG1 and EG2 positive eosinophils and their clinical significance in asthmatics].
    Huang H, Xu J, Zhong N.
    Zhonghua Jie He He Hu Xi Za Zhi; 1998 Oct; 21(10):612-4. PubMed ID: 11477881
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Reactivity of monoclonal antibodies EG1 and EG2 with eosinophils and their granule proteins.
    Nakajima H, Loegering DA, Kita H, Kephart GM, Gleich GJ.
    J Leukoc Biol; 1999 Sep; 66(3):447-54. PubMed ID: 10496315
    [Abstract] [Full Text] [Related]

  • 16. A new method for the quantification of neutrophil and eosinophil cationic proteins in feces: establishment of normal levels and clinical application in patients with inflammatory bowel disease.
    Peterson CG, Eklund E, Taha Y, Raab Y, Carlson M.
    Am J Gastroenterol; 2002 Jul; 97(7):1755-62. PubMed ID: 12135031
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Increased portal tract infiltration of mast cells and eosinophils in primary biliary cirrhosis.
    Nakamura A, Yamazaki K, Suzuki K, Sato S.
    Am J Gastroenterol; 1997 Dec; 92(12):2245-9. PubMed ID: 9399763
    [Abstract] [Full Text] [Related]

  • 20. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
    Langhorst J, Junge A, Rueffer A, Wehkamp J, Foell D, Michalsen A, Musial F, Dobos GJ.
    Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.